Clinical trial
EVALUATION OF BOTULINUM TOXIN IN THE PALATOPHARYNGEAL MUSCLE FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNEA
NCT07399782 is registered in ClinicalTrials.gov with Hospital Felicio Rocho as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EVALUATION OF BOTULINUM TOXIN IN THE PALATOPHARYNGEAL MUSCLE FOR THE TREATMENT OF OBSTRUCTIVE SLEEP APNEA
- Lead sponsor
- Hospital Felicio Rocho
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- April 5, 2026
- Completion date
- September 1, 2026
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sleep apnea - obstructive, sleep apnea syndrome (osas), sleep apnea syndrome, obstructive, sleep apnea/hypopnea syndrome